trial · primary record
ALKS 7290 Dose
Major Depressive Disorder (MDD)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 180 |
| Primary completion | 2028-01 |
| Primary endpoint | Incidence of treatment-emergent adverse events |
| Registry ID | NCT07901179 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:56.507Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07901179
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.